Skip to main content
. 2015 Jan 27;13:26. doi: 10.1186/s12967-015-0385-4

Table 1.

Vemurafenib and barasertib activity evaluation in living cell lines

Cell line BRAF status 3 days-vemurafenib 3 days-barasertib-HQPA
IC 50 (μM) IC 50 (nM)
MBA72 V600E 3.2 ± 0.6 305 ± 4
Hmel-1 V600K 5.5 ± 0.4 311 ± 6
LND1 wild type 32.2 ± 1.1 307 ± 7
HBL wild type 37.3 ± 0.9 315 ± 11
MBA72R V600E 33.5 ± 0.5 367 ± 10
Hmel-1R V600K 25.8 ± 0.5 184 ± 8